Literature DB >> 23105219

Maple syrup urine disease: An uncommon cause for neonatal metabolic distress.

R Christopher1, S V Babu, L Nirmala, G R Rangaswamy, C P Narayan, K T Shetty.   

Abstract

Maple Syrup Urine Disease is an autosomal recessive disorder caused by a deficiency in the activity of the branched-chain α-ketoacid dehydrogenase complex. This rare disorder represents one of the causes of acute neonatal illness which results in devastating disturbances of neurological development. On investigation of 1750 infants with neurological impairment for inborn errors of amino acid metabolism, 4 neonates with classical maple syrup urine disease were detected. These otherwise normal neonates presented in the first week after birth with seizures, lethargy and refusal of feeds, hypoglycemia and metabolic acidosis. The plasma and urine concentrations of the branched-chain amino acids were increased and there was ketoaciduria. Two of these neonates expired before specific treatment could be instituted. Routine biochemical screening of neonates with acute illness could unearth many cases of this rare inherited metabolic disease.

Entities:  

Keywords:  Leucine; inherited metabolic disorder; isoleucine; valine; α-ketoacids

Year:  1999        PMID: 23105219      PMCID: PMC3453579          DOI: 10.1007/BF02867919

Source DB:  PubMed          Journal:  Indian J Clin Biochem        ISSN: 0970-1915


  10 in total

1.  Inhibition of brain glutamic acid decarboxylase by phenylalanine, valine, and leucine derivatives: a suggestion concerning the etiology of the neurological defect in phenylketonuria and branched-chain ketonuria.

Authors:  R E TASHIAN
Journal:  Metabolism       Date:  1961-05       Impact factor: 8.694

2.  Leucine-induced hypoglycemia. I. Clinical observations and diagnostic considerations.

Authors:  C C MABRY; A M DIGEORGE; V H AUERBACH
Journal:  J Pediatr       Date:  1960-10       Impact factor: 4.406

3.  A new syndrome: progressive familial infantile cerebral dysfunction associated with an unusual urinary substance.

Authors:  J H MENKES; P L HURST; J M CRAIG
Journal:  Pediatrics       Date:  1954-11       Impact factor: 7.124

4.  Neonatal screening for amino acidaemias in Karnataka, south India.

Authors:  N A Rao; A R Devi; H S Savithri; S V Rao; A H Bittles
Journal:  Clin Genet       Date:  1988-07       Impact factor: 4.438

5.  Hypoglycemia and maple syrup urine disease: defective gluconeogenesis.

Authors:  M W Haymond; I E Karl; R D Feigin; D DeVivo; A S Pagliara
Journal:  Pediatr Res       Date:  1973-05       Impact factor: 3.756

6.  Inhibition of brain protein synthesis: an approach to the biochemical basis of neurological dysfunction in the amino-acidurias.

Authors:  S H Appel
Journal:  Trans N Y Acad Sci       Date:  1966-11

7.  A rapid method for assay of branched-chain keto acid decarboxylation in cultured cells and its application to prenatal diagnosis of maple syrup urine disease.

Authors:  A H Fensom; P F Benson; J E Baker
Journal:  Clin Chim Acta       Date:  1978-07-01       Impact factor: 3.786

8.  Serotonin depletion by dietary leucine.

Authors:  A Yuwiler; E Geller
Journal:  Nature       Date:  1965-10-02       Impact factor: 49.962

9.  Hypoglycemia in maple syrup urine disease.

Authors:  G N Donnell; E Lieberman; K N Shaw; R Koch
Journal:  Am J Dis Child       Date:  1967-01

10.  Gas-chromatographic method of analysis for urinary organic acids. II. Description of the procedure, and its application to diagnosis of patients with organic acidurias.

Authors:  K Tanaka; A West-Dull; D G Hine; T B Lynn; T Lowe
Journal:  Clin Chem       Date:  1980-12       Impact factor: 8.327

  10 in total
  1 in total

1.  Maple syrup urine disease and oculocutaneous albinism in twins.

Authors:  Divya Nagabushana; Asha Benakappa
Journal:  J Clin Neonatol       Date:  2014-01
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.